J1320 HCPCS Level II Code: Injection, amitriptyline hcl, up to 20 mg
Medicare Coverage & Payment
- CMS short descriptor: Amitriptyline injection
- Medicare coverage: Special coverage instructions apply (CMS coverage code D)
- Payment category: Drugs (pricing indicator 51)
- BETOS: O1E — Other drugs
- Last CMS action effective: January 1, 1997
Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.
Change history
- January 1, 1982Added to the code setInjection, amitriptyline hcl, up to 20 mg
Contextual Map
Every relationship of J1320 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
Nearest codes (20)
- J1300 — Injection, eculizumab, 10 mg[Sibling]
- J1301 — Injection, edaravone, 1 mg[Sibling]
- J1302 — Injection, sutimlimab-jome, 10 mg[Sibling]
- J1303 — Injection, ravulizumab-cwvz, 10 mg[Sibling]
- J1304 — Injection, tofersen, 1 mg[Sibling]
- J1305 — Injection, evinacumab-dgnb, 5mg[Sibling]
- J1306 — Injection, inclisiran, 1 mg[Sibling]
- J1307 — Injection, crovalimab-akkz, 10 mg[Sibling]
- and 12 more
Change history
- January 1, 1982 — Added to the code set [Change history]
Nearest Codes in This Family
Official HCPCS Level II classifications closest to J1320 in its code family, with their registry titles.
- J1304 — Injection, tofersen, 1 mg
- J1305 — Injection, evinacumab-dgnb, 5mg
- J1306 — Injection, inclisiran, 1 mg
- J1307 — Injection, crovalimab-akkz, 10 mg
- J1308 — Injection, famotidine, 0.25 mg
- J1322 — Injection, elosulfase alfa, 1 mg
- J1323 — Injection, elranatamab-bcmm, 1 mg
- J1324 — Injection, enfuvirtide, 1 mg
- J1325 — Injection, epoprostenol, 0.5 mg
- J1326 — Injection, zolbetuximab-clzb, 2 mg